The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP-lprlpr mice

doi:10.1084/jem.183.4.1447

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Huang, F. P.
	Articles by Liew, F. Y.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Huang, F. P.
	Articles by Liew, F. Y.


Social Bookmarking

	What's this?

ARTICLES

The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP-lprlpr mice

FP Huang, GJ Feng, G Lindop, DI Stott and FY Liew
Department of Immunology, University of Glasgow, United Kingdom.

MRL/MP-lpr/lpr (MRL/lpr) mice develop a spontaneous autoimmune disease. Serum from these mice contained significantly higher concentrations of nitrite/nitrate than serum from age-matched control MRL/MP-+/+ (MRL/+), BALB/c or CBA/6J mice. Spleen and peritoneal cells from MRL/lpr mice also produced significantly more nitric oxide (NO) than those from the control mice when cultured with interferon (IFN) gamma and lipopolysaccharide (LPS) in vitro. It is interesting to note that peritoneal cells from MRL/lpr mice also produced markedly higher concentrations of interleukin (IL) 12 than those from MRL/+ or BALB/c mice when cultured with same stimuli. It is striking that cells from MRL/lpr mice produced high concentrations of NO when cultured cells from MRL/+ or BALB/c mice. The enhanced NO synthesis induced by IFN- gamma/LPS was substantially inhibited by anti-IL-12 antibody. In addition, IL-12-induced NO production can also be markedly inhibited by anti-IFN-gamma antibody, but only weakly inhibited by anti-tumor necrosis factor alpha antibody. The effect of IL-12 on NO production was dependent on the presence of natural killer and possibly T cells. Serum from MRL/lpr mice contained significantly higher concentrations of IL-12 compared with those of MRL/+ or BALB/c control mice. Daily injection of recombinant IL-12 led to increased serum levels of IFN- gamma and NO metabolites, and accelerated glomerulonephritis in the young MRL/lpr mice (but not in the MRL/+ mice) compared with controls injected with phosphate-buffered saline alone. These data, together with previous finding that NO synthase inhibitors can ameliorate autoimmune disease in MRL/lpr mice, suggest that high capacity of such mice to produce IL-12 and their greater responsiveness to IL-12, leading to the production of high concentrations of NO, are important factors in this spontaneous model of autoimmune disease.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Neumann, D., Tschernig, T., Popa, D., Schmiedl, A., de Lema, G. P., Resch, K., Martin, M. U. (2006). Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms. Int Immunol 18: 1779-1787 [Abstract] [Full Text]
Jimenez-Caliani, A. J., Jimenez-Jorge, S., Molinero, P., Fernandez-Santos, J. M., Martin-Lacave, I., Rubio, A., Guerrero, J. M., Osuna, C. (2006). Sex-Dependent Effect of Melatonin on Systemic Erythematosus Lupus Developed in Mrl/Mpj-Faslpr Mice: It Ameliorates the Disease Course in Females, whereas It Exacerbates It in Males. Endocrinology 147: 1717-1724 [Abstract] [Full Text]
Pawar, R. D., Patole, P. S., Zecher, D., Segerer, S., Kretzler, M., Schlondorff, D., Anders, H.-J. (2006). Toll-Like Receptor-7 Modulates Immune Complex Glomerulonephritis. J. Am. Soc. Nephrol. 17: 141-149 [Abstract] [Full Text]
Patole, P. S., Grone, H.-J., Segerer, S., Ciubar, R., Belemezova, E., Henger, A., Kretzler, M., Schlondorff, D., Anders, H.-J. (2005). Viral Double-Stranded RNA Aggravates Lupus Nephritis through Toll-Like Receptor 3 on Glomerular Mesangial Cells and Antigen-Presenting Cells. J. Am. Soc. Nephrol. 16: 1326-1338 [Abstract] [Full Text]
Reilly, C. M., Mishra, N., Miller, J. M., Joshi, D., Ruiz, P., Richon, V. M., Marks, P. A., Gilkeson, G. S. (2004). Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid. J. Immunol. 173: 4171-4178 [Abstract] [Full Text]
Kyttaris, V C, Juang, Y-T, Tsokos, G C (2004). Gene therapy in systemic lupus erythematosus. Lupus 13: 353-358 [Abstract]
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D. (2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev. 17: 174-207 [Abstract] [Full Text]
Bossu, P., Neumann, D., Del Giudice, E., Ciaramella, A., Gloaguen, I., Fantuzzi, G., Dinarello, C. A., Di Carlo, E., Musiani, P., Meroni, P. L., Caselli, G., Ruggiero, P., Boraschi, D. (2003). IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc. Natl. Acad. Sci. USA 100: 14181-14186 [Abstract] [Full Text]
Kikawada, E., Lenda, D. M., Kelley, V. R. (2003). IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology. J. Immunol. 170: 3915-3925 [Abstract] [Full Text]
Anders, H.-J., Banas, B., Linde, Y., Weller, L., Cohen, C. D., Kretzler, M., Martin, S., Vielhauer, V., Schlondorff, D., Grone, H.-J. (2003). Bacterial CpG-DNA Aggravates Immune Complex Glomerulonephritis: Role of TLR9-Mediated Expression of Chemokines and Chemokine Receptors. J. Am. Soc. Nephrol. 14: 317-326 [Abstract] [Full Text]
Lopez-Nevot, M. A., Ramal, L., Jimenez-Alonso, J., Martin, J. (2003). The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 42: 113-116 [Abstract] [Full Text]
Esfandiari, E., McInnes, I. B., Lindop, G., Huang, F.-P., Field, M., Komai-Koma, M., Wei, X.-q., Liew, F. Y. (2001). A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease. J. Immunol. 167: 5338-5347 [Abstract] [Full Text]
Neumann, D., Del Giudice, E., Ciaramella, A., Boraschi, D., Bossu, P. (2001). Lymphocytes from Autoimmune MRL lpr/lpr Mice Are Hyperresponsive to IL-18 and Overexpress the IL-18 Receptor Accessory Chain. J. Immunol. 166: 3757-3762 [Abstract] [Full Text]
Khalil, M., Inaba, K., Steinman, R., Ravetch, J., Diamond, B. (2001). T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus. J. Immunol. 166: 1667-1674 [Abstract] [Full Text]
Hesse, M., Cheever, A. W., Jankovic, D., Wynn, T. A. (2000). NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous Disease. Am. J. Pathol. 157: 945-955 [Abstract] [Full Text]
Satoh, M., Weintraub, J. P., Yoshida, H., Shaheen, V. M., Richards, H. B., Shaw, M., Reeves, W. H. (2000). Fas and Fas Ligand Mutations Inhibit Autoantibody Production in Pristane-Induced Lupus. J. Immunol. 165: 1036-1043 [Abstract] [Full Text]
Reilly, C. M., Oates, J. C., Cook, J. A., Morrow, J. D., Halushka, P. V., Gilkeson, G. S. (2000). Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-{gamma} Agonists. J. Immunol. 164: 1498-1504 [Abstract] [Full Text]
Schwarting, A., Tesch, G., Kinoshita, K., Maron, R., Weiner, H. L., Kelley, V. R. (1999). IL-12 Drives IFN-{gamma}-Dependent Autoimmune Kidney Disease in MRL-Faslpr Mice. J. Immunol. 163: 6884-6891 [Abstract] [Full Text]
Willenborg, D. O., Fordham, S. A., Staykova, M. A., Ramshaw, I. A., Cowden, W. B. (1999). IFN-{gamma} Is Critical to the Control of Murine Autoimmune Encephalomyelitis and Regulates Both in the Periphery and in the Target Tissue: A Possible Role for Nitric Oxide. J. Immunol. 163: 5278-5286 [Abstract] [Full Text]
Zavala, F., Masson, A., Hadaya, K., Ezine, S., Schneider, E., Babin, O., Bach, J.-F. (1999). Granulocyte-Colony Stimulating Factor Treatment of Lupus Autoimmune Disease in MRL-lpr/lpr Mice. J. Immunol. 163: 5125-5132 [Abstract] [Full Text]
Lee, T.-S., Yen, H.-C., Pan, C.-C., Chau, L.-Y. (1999). The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice. Arterioscler. Thromb. Vasc. Bio. 19: 734-742 [Abstract] [Full Text]
Schwacha, M. G., Meissler, J. J. Jr., Eisenstein, T. K. (1998). Salmonella typhimurium Infection in Mice Induces Nitric Oxide-Mediated Immunosuppression through a Natural Killer Cell-Dependent Pathway. Infect. Immun. 66: 5862-5866 [Abstract] [Full Text]
Salvucci, O., Kolb, J. P., Dugas, B., Dugas, N., Chouaib, S. (1998). The Induction of Nitric Oxide by Interleukin-12 and Tumor Necrosis Factor-alpha in Human Natural Killer Cells: Relationship With the Regulation of Lytic Activity. Blood 92: 2093-2102 [Abstract] [Full Text]
Huang, F.-P., Xu, D., Esfandiari, E.-O, Sands, W., Wei, X.-q., Liew, F. Y. (1998). Cutting Edge: Mice Defective in Fas Are Highly Susceptible to Leishmania major Infection Despite Elevated IL-12 Synthesis, Strong Th1 Responses, and Enhanced Nitric Oxide Production. J. Immunol. 160: 4143-4147 [Abstract] [Full Text]
Schwarting, A., Moore, K., Wada, T., Tesch, G., Yoon, H.-J., Kelley, V. R. (1998). IFN-{gamma} Limits Macrophage Expansion in MRL-Faslpr Autoimmune Interstitial Nephritis: A Negative Regulatory Pathway. J. Immunol. 160: 4074-4081 [Abstract] [Full Text]
Peng, S. L., Moslehi, J., Robert, M. E., Craft, J. (1998). Perforin Protects Against Autoimmunity in Lupus-Prone Mice. J. Immunol. 160: 652-660 [Abstract] [Full Text]
Rieser, C., Bock, G., Klocker, H., Bartsch, G., Thurnher, M. (1997). Prostaglandin E2 and Tumor Necrosis Factor alpha �Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12�Production. J. Exp. Med. 186: 1603-1608 [Abstract] [Full Text]
Gilkeson, G. S., Mudgett, J. S., Seldin, M. F., Ruiz, P., Alexander, A. A., Misukonis, M. A., Pisetsky, D. S., Weinberg, J. B. (1997). Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2�. J. Exp. Med. 186: 365-373 [Abstract] [Full Text]